FASTQ

Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing

Retrieved on: 
torsdag, maj 30, 2024
Software, Research, Pharmaceutical, Oncology, Data Management, Technology, Genetics, Health Technology, Science, Biotechnology, Stem Cells, Health, FASTQ, Developmental biology, Data analysis, Parsing, Acquisition, Transcriptome, Mobile phone

Parse Biosciences , a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Trailmaker™, its user-friendly cloud platform purpose-built for single cell data analysis.

Key Points: 
  • Parse Biosciences , a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Trailmaker™, its user-friendly cloud platform purpose-built for single cell data analysis.
  • Fast, scalable, and capable of providing end-to-end analysis, Trailmaker removes common analysis barriers, rapidly transforming single cell data into biological insights.
  • "Traditional single cell data analysis presents a number of challenges, including data processing, visualization, data integration and interpretation, as well as a shortage of experts who can process the data," noted Parse Biosciences co-founder and CTO Charlie Roco.
  • Already in use by over 4,500 researchers, the rebranded and enhanced data analysis platform is now officially available to Parse Biosciences’ customers and all academic researchers free of charge.

MGI Showcases Life Science Excellence at ESCMID Global 2024 with Latest DNBSEQ-E25 Sequencer and New Partnership with ABL Diagnostics

Retrieved on: 
måndag, april 29, 2024
Infection, Congress, E25, Genomics, ABL, Laboratory, Health, ESCMID, Software, Business development, ECCMID, Partnership, Research, Workflow, NGS, DNA, DNB, Patient, Microbiology, MGI, Database, HIV, PFI, Exhibition, FASTQ, DNA sequencing, Tuberculosis

During the event taking place from 27-30 April in Barcelona, MGI and ABL Diagnostics (Woippy, France, Euronext: ABLD – ISIN: FR001400AHX6) are pleased to announce its partnership and the compatibility of ABL Diagnostics' DeepChek® assays with MGI's DNBSEQ™ platforms.

Key Points: 
  • During the event taking place from 27-30 April in Barcelona, MGI and ABL Diagnostics (Woippy, France, Euronext: ABLD – ISIN: FR001400AHX6) are pleased to announce its partnership and the compatibility of ABL Diagnostics' DeepChek® assays with MGI's DNBSEQ™ platforms.
  • "Once again, MGI showcases our commitment to supporting healthcare and scientific research and applications across Europe and Africa.
  • We at MGI believe that the power and potential of genomics are boundless," said Dr. Yong Hou, General Manager of MGI Europe and Africa.
  • Moreover, at this year's ESCMID Global 2024, MGI announced a technical assessment of solutions by ABL Diagnostics (ABL), a Euronext-listed company that develops molecular biology assays and software for microbiology genotyping.

Element Biosciences and DNAnexus® Announce Collaboration to Advance Multi-Omics Analysis

Retrieved on: 
tisdag, februari 6, 2024
Cloud, Transfer, SAN, Science, Research, Ecosystem, FASTQ, SVP, DNAnexus, Doctor of Philosophy, Element

SAN DIEGO, Feb. 6, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, announced a collaboration with DNAnexus, provider of the Precision Health Data Cloud, to allow customers to stream data from Element's AVITI™ System directly to their DNAnexus account. The collaboration combines the unmatched performance of AVITI sequencing with the secure and full-featured multi-omic analysis platform of DNAnexus.  The integration of AVITI with DNAnexus will be available to customers in Q1 2024.

Key Points: 
  • The collaboration combines the unmatched performance of AVITI sequencing with the secure and full-featured multi-omic analysis platform of DNAnexus.
  • "We are thrilled to have DNAnexus as a partner in the growing Element Biosciences analysis ecosystem," said Francisco Garcia, PhD, SVP of Informatics at Element Biosciences, speaking at the Advances in Genome Biology and Technology (AGBT) 2024 conference.
  • "This collaboration provides our customers with direct integration to DNAnexus' robust, flexible and user-friendly multi-modal analysis platform."
  • "Element Biosciences has established itself as a leading sequencing technology innovator and we are proud to join forces to help streamline multi-omics research."

Singleron launches the AccuraSCOPE® Single Cell Transcriptome

Retrieved on: 
tisdag, januari 30, 2024
RNA-Seq, DNA, RNA, Workflow, Chromosome, Transcriptome, Disease, FASTQ, Genome, Data analysis, Messenger, Alternative splicing, Medicine, Computer data storage

COLOGNE, Germany, Jan. 30, 2024 /PRNewswire/ -- Singleron Biotechnologies, a leader in single cell multi-omic solutions for precision medicine, announced two new commercial product launches : AccuraSCOPE® Single Cell Transcriptome and Genome Library Kit and the AccuraSCOPE® Single Cell Full-Length Transcriptome Library Kit.

Key Points: 
  • COLOGNE, Germany, Jan. 30, 2024 /PRNewswire/ -- Singleron Biotechnologies, a leader in single cell multi-omic solutions for precision medicine, announced two new commercial product launches : AccuraSCOPE® Single Cell Transcriptome and Genome Library Kit and the AccuraSCOPE® Single Cell Full-Length Transcriptome Library Kit.
  • AccuraSCOPE  Single Cell Transcriptome and Genome Library Kit opens new possibilities for single cell multi-omic analysis by profiling the entire genome and transcriptome simultaneously.
  • In addition to single cell RNA sequencing, this method enables deep single cell genome sequencing, amplifying ultra-low quantities of DNA from individual cells.
  • It enables the detection of alternative splicing at the single cell level, substantially reducing hands-on time compared to existing full-length single cell RNAseq methods.

Dante Genomics offers free, first-step feature of its AVANTI Software to turn FASTQ to VCF files on its platform agnostic genomic interpretation software

Retrieved on: 
måndag, maj 15, 2023
DNA, VCF, Microsoft Windows, Genomics, FASTQ, NGS, Complete Genomics, Microsoft, Software, Ultima, Patient, AVANTI, Medicine, Element, Neurology, MGI, Antibiotics, Medical imaging, Illumina

NEW YORK, May 15, 2023 /PRNewswire/ -- Dante Genomics, a global leader in genomics and precision medicine, today announced a free, initial feature of its platform agnostic proprietary B2B software to automatically turn FASTQ files to VCF files at no charge as an introduction to its AVANTI Software, demonstrating the broad scalability of its interpretation software to benefit sequencing labs of all sizes around the world.

Key Points: 
  • The transformation to VCF is difficult and complicated and would normally require an expert IT team to accomplish.
  • In offering the transformation for free, Dante is demonstrating the utility of this plug-and-play approach to genomic interpretation at scale.
  • The AVANTI Software is platform agnostic and compatible with all sequencers, including Illumina, Pac Bio, Oxford Nanopore, Complete Genomics, Ultima, Element and MGI, among others.
  • To learn more about Dante's AVANTI Software and to sign up and start generating reports in minutes, visit https://avanti.dantegenomics.com .

Dante Genomics offers free, first-step feature of its AVANTI Software to turn FASTQ to VCF files on its platform agnostic genomic interpretation software

Retrieved on: 
måndag, maj 15, 2023
DNA, VCF, Microsoft Windows, Genomics, FASTQ, NGS, Complete Genomics, Microsoft, Software, Ultima, Patient, AVANTI, Medicine, Element, Neurology, MGI, Antibiotics, Medical imaging, Illumina

NEW YORK, May 15, 2023 /PRNewswire/ -- Dante Genomics, a global leader in genomics and precision medicine, today announced a free, initial feature of its platform agnostic proprietary B2B software to automatically turn FASTQ files to VCF files at no charge as an introduction to its AVANTI Software, demonstrating the broad scalability of its interpretation software to benefit sequencing labs of all sizes around the world.

Key Points: 
  • The transformation to VCF is difficult and complicated and would normally require an expert IT team to accomplish.
  • In offering the transformation for free, Dante is demonstrating the utility of this plug-and-play approach to genomic interpretation at scale.
  • The AVANTI Software is platform agnostic and compatible with all sequencers, including Illumina, Pac Bio, Oxford Nanopore, Complete Genomics, Ultima, Element and MGI, among others.
  • To learn more about Dante's AVANTI Software and to sign up and start generating reports in minutes, visit https://avanti.dantegenomics.com .

Element Biosciences Accelerates Data Discoveries with Amazon Omics

Retrieved on: 
måndag, maj 15, 2023
BAM, Amazon Web Services, VCF, Linux, FASTQ, Data analysis, API, Gene expression, Doctor of Philosophy, Cloud computing, SAN, Element, SVP, AWS, Online shopping, Computer data storage, Software, Informatics

SAN DIEGO, May 15, 2023 /PRNewswire/ -- Element Biosciences, Inc.— developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry — announced it is now leveraging a new Amazon Omics feature, Ready2Run workflows, to provide simple, powerful, and cost-effective analysis workflows. The combination of technologies gives customers the option to stream their sequencing data from AVITI™ directly to the cloud and automatically perform subsequent analysis using Amazon Omics.

Key Points: 
  • The combination of technologies gives customers the option to stream their sequencing data from AVITI™ directly to the cloud and automatically perform subsequent analysis using Amazon Omics.
  • Amazon Omics is a service from Amazon Web Services (AWS) that helps remove the heavy lifting from storing, querying, and analyzing various omics data.
  • Element's Bases2Fastq Ready2Run workflows on Amazon Omics enable customers to stream their sequencing data from AVITI and perform analysis on Amazon Omics.
  • "We're excited to be working with companies like Element Biosciences to offer pre-built workflows as part of the new Ready2Run feature in Amazon Omics," said Tehsin Syed, General Manager of Health AI, AWS.

OmniTier Unveils the Industry's First On-Premise, Standalone, End-To-End Genomic Analysis Appliance, at Cost Below $50 Per WGS Sample, at Scale

Retrieved on: 
tisdag, april 18, 2023
Spectrum, Single-nucleotide polymorphism, FASTQ, NGS, GIS, GWAS, Genomics, SAN, McDonnell Genome Institute, CGD, WGS, Research, WES, Next Generation, ACMG, Antibiotics

SAN JOSE, Calif., April 18, 2023 /PRNewswire/ -- OmniTier Inc, a leader in on-premise genomics analysis products, today launched the industry's first on-premise, standalone appliance for both human genomic data analysis (secondary analysis) and biomedical data interpretation (tertiary analysis), called CompStor Spectrum™. Benefitting from proprietary AI, acceleration technology and built-in automation, CompStor Spectrum™ can produce high volume genomics test reports at an average cost per whole genome sequencing (WGS) analysis of less than $50 each.

Key Points: 
  • Benefitting from proprietary AI, acceleration technology and built-in automation, CompStor Spectrum™ can produce high volume genomics test reports at an average cost per whole genome sequencing (WGS) analysis of less than $50 each.
  • Research and clinical organizations, and genomic services providers can benefit from CompStor Spectrum™ by achieving large cost savings, from automated end-to-end sample analysis, and increased data security from on-premise or private cloud deployments.
  • OmniTier genomic analysis appliances are installed in an organization's own IT data center and operated by bioinformaticians or geneticists through their local browser.
  • "CompStor® Spectrum is designed to complement the cost reduction in sample costs announced by sequencer suppliers, to make WGS and WES analysis and testing more affordable."

Dante Genomics launches Avanti Software for a plug-and-play genomic interpretation that takes minutes instead of hours

Retrieved on: 
måndag, mars 20, 2023
FASTQ, NGS, Running, VCF, UI, Software, Genomics, Medicine, Antibiotics, Avanti

Avanti provides clinicians, geneticists and researchers with a plug-and-play web-based software UI that generates reports in less than five minutes, in parallel, for whole genome, whole exome, target panels and other NGS datasets.

Key Points: 
  • Avanti provides clinicians, geneticists and researchers with a plug-and-play web-based software UI that generates reports in less than five minutes, in parallel, for whole genome, whole exome, target panels and other NGS datasets.
  • Avanti software is platform agnostic, meaning no matter what sequencer is used, Avanti returns genomic reports and enhances the genomic offering of doctors and researchers.
  • With Avanti, clinics and researchers gain the software needed to boost their genomic interpretation," said Andrea Riposati, CEO of Dante Genomics.
  • Avanti software uses the raw data output of any sequencer as an input to create genomic reports with clinical utility and actionable medical insights.

Dante Genomics launches Avanti Software for a plug-and-play genomic interpretation that takes minutes instead of hours

Retrieved on: 
måndag, mars 20, 2023
FASTQ, NGS, Running, VCF, UI, Software, Genomics, Medicine, Antibiotics, Avanti

Avanti provides clinicians, geneticists and researchers with a plug-and-play web-based software UI that generates reports in less than five minutes, in parallel, for whole genome, whole exome, target panels and other NGS datasets.

Key Points: 
  • Avanti provides clinicians, geneticists and researchers with a plug-and-play web-based software UI that generates reports in less than five minutes, in parallel, for whole genome, whole exome, target panels and other NGS datasets.
  • Avanti software is platform agnostic, meaning no matter what sequencer is used, Avanti returns genomic reports and enhances the genomic offering of doctors and researchers.
  • With Avanti, clinics and researchers gain the software needed to boost their genomic interpretation," said Andrea Riposati, CEO of Dante Genomics.
  • Avanti software uses the raw data output of any sequencer as an input to create genomic reports with clinical utility and actionable medical insights.